Content deleted Content added
Citation bot (talk | contribs) Alter: url. URLs might have been anonymized. Add: authors 1-1. Removed parameters. Some additions/deletions were parameter name changes. | Use this bot. Report bugs. | Suggested by AManWithNoPlan | #UCB_CommandLine |
No edit summary |
||
Line 45:
In August 2007, Abraxis announced it would again undergo a restructuring to separate its "hospital-based products business" from its "proprietary products business" into two public companies; this would involve the merging of Abraxis Oncology and Abraxis Research sub-units to form a new Abraxis Bioscience (Abraxis Bioscience, Inc., {{NASDAQ|ABII}}), and the spinoff of Abraxis Pharmaceutical Products (APP, Inc., {{NASDAQ|APPX}}).<ref>{{Cite news|url = http://www.highbeam.com/doc/1P3-1345586341.html|archive-url = https://web.archive.org/web/20150924202900/http://www.highbeam.com/doc/1P3-1345586341.html|url-status = dead|archive-date = 24 September 2015|title = Abraxis BioScience Plans to Separate into Two Companies|last = Van Arnum|first = Patricia|date = 1 August 2007|work = Pharmaceutical Technology|access-date = 2015-08-07|via = [[Highbeam Research]]}}</ref> This reorganization was completed in November 2007.<ref name=":0">{{Cite report|date = 13 November 2007|title = FORM 8-K|url = https://www.sec.gov/Archives/edgar/data/1409012/000119312507250450/d8k.htm|first = Lisa|last = Gopalakrishnan|publisher = United States Securities and Exchange Commission|access-date = 2015-08-07}}</ref> During the reorganization, the new Abraxis Bioscience was known briefly as '''New Abraxis'''.<ref name=":0" />
In 2010, Abraxis BioScience was acquired by [[Celgene Corporation]].<ref name="ir.celgene.com"/> Per Celgene's website, as of at least 2016 Abraxis no longer exists as a named division within Celgene.{{Citation needed|date=September 2023}}
== References ==
| |||